Miravitlles, MarcVerhamme, Katia M.C.Calverley, Peter M. A.Dreher, MichaelBayer, ValentinaGardev, Asparuhde la Hoz, AlbertoWedzicha, Jadwiga APrice, David2022-03-112022-03-112022-03-11Miravitlles, M, Verhamme, K M C, Calverley, P M A, Dreher, M, Bayer, V, Gardev, A, de la Hoz, A, Wedzicha, J A & Price, D 2022, 'A pooled analysis of mortality in patients with COPD receiving dual bronchodilation with and without additional inhaled corticosteroid', International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 545—558. https://doi.org/10.2147/COPD.S3501671176-9106https://hdl.handle.net/2164/18192Acknowledgements Support for this project was provided by Boehringer Ingelheim International GmbH (BI). The authors did not receive payment related to the development of the manuscript. Medical writing assistance, in the form of the preparation and revision of the manuscript, was supported financially by BI and provided by Vicki Cronin of MediTech Media, under the authors’ conceptual direction and based on feedback from the authors. BI was given the opportunity to review the manuscript for medical and scientific accuracy as well as intellectual property considerations. The authors would like to thank Wenqiong Xue for her contributions to the statistical analysis.141152045engCOPDexacerbation historyinhaled corticosteroidlong-acting β2-agonistlong-acting muscarinic antagonistmortalityR MedicineSupplementary DataRJournal article10.2147/COPD.S35016717